Stay updated on Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe footer now displays Revision: v3.6.4, replacing v3.6.3, indicating a new release of the site interface.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedStudy Record History now shows a new release entry: Revision: v3.6.3, and the preceding Revision: v3.6.2 entry has been removed. This updates the revision log to reflect the latest platform update.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a new software release has been deployed for the page.SummaryDifference0.0%

- Check53 days agoChange DetectedThe history now shows recruitment is closed, with the note that no longer looking for participants. The version in the history updates to Revision: v3.6.0, replacing the prior Revision: v3.5.5.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision label changed from v3.5.4 to v3.5.5 in the page header, signaling a newer build/version reference. It represents a metadata update rather than a modification to study content.SummaryDifference0.0%

- Check67 days agoChange DetectedVersion 109 posted on 2026-05-28 adds Study Design, Study Status, and Recruitment Status. The record now shows the study as Completed, replacing the previous Active, not recruiting status that was removed on 2026-04-08.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.